Table 3.
Potential for an ADE by class of conflicting information
| Discrepancy class | No PADE, N (%) | Mild/moderate PADE, N (%) | Severe PADE, N (%) |
| Complex regimen | 6 (1.28) | 100 (21.28) | 31 (6.60) |
| Dosage range expanded inappropriately | 4 (0.85) | 66 (14.04) | 6 (1.28) |
| Frequency mismatch | 14 (2.98) | 44 (9.36) | 8 (1.70) |
| PRN mismatch | 15 (3.19) | 32 (6.81) | 11 (2.34) |
| Dose mismatch | 1 (0.21) | 42 (8.94) | 15 (3.19) |
| Imprecise conversion of daytime and around-the-clock frequencies | 18 (3.83) | 4 (0.85) | 0 |
| Frequency range extended inappropriately | 8 (1.70) | 9 (1.91) | 2 (0.43) |
| Route mismatch | 3 (0.64) | 10 (2.13) | 4 (0.85) |
| Dosage form mismatch | 7 (1.49) | 3 (0.64) | 0 |
| Duration mismatch | 0 | 3 (0.64) | 1 (0.21) |
| Quantity mismatch | 0 | 2 (0.43) | 0 |
| Drug name mismatch | 0 | 0 | 1 (0.21) |
Percentages represent a fraction of total prescriptions examined.
ADE, adverse drug event; PADE, potential adverse drug event.